{{Rsnum
|rsid=2524005
|Gene=HLA-U
|Chromosome=6
|position=29931900
|Orientation=minus
|GMAF=0.1556
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 61.3 | 36.0 | 2.7
| HCB | 68.1 | 30.4 | 1.5
| JPT | 59.3 | 37.2 | 3.5
| YRI | 58.2 | 37.0 | 4.8
| ASW | 76.8 | 23.2 | 0.0
| CHB | 68.1 | 30.4 | 1.5
| CHD | 77.8 | 19.4 | 2.8
| GIH | 39.6 | 51.0 | 9.4
| LWK | 83.6 | 15.5 | 0.9
| MEX | 73.7 | 22.8 | 3.5
| MKK | 65.8 | 29.7 | 4.5
| TSI | 68.3 | 29.7 | 2.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22688191
|Trait=None
|Title=Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder.
|RiskAllele=
|Pval=5E-7
|OR=1.3200
|ORtxt=None
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}